Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel J Church

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Experimental Biology and Medicine (Maywood, N.J.)|November 4, 2017
In silico modeling to optimize interpretation of liver safety biomarkers in clinical trialsRachel J Church, Paul B Watkins
Clinical and Translational Science|October 28, 2020
The Challenge of Interpreting Alanine Aminotransferase Elevations in Clinical Trials of New Drug CandidatesRachel J Church, Paul B Watkins
Hepatology (Baltimore, Md.)|March 6, 2018
ReplyRachel J Church, Paul B Watkins
Journal of Digestive Diseases|November 1, 2018
Serum biomarkers of drug-induced liver injury: Current status and future directionsRachel J Church, Paul B Watkins
Liver International : Official Journal of the International Association for the Study of the Liver|April 8, 2017
The transformation in biomarker detection and management of drug-induced liver injuryRachel J Church, Paul B Watkins
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 2012
Prostaglandin E(2) produced by the lung augments the effector phase of allergic inflammationRachel J Church, Leigh A Jania, Beverly H Koller
Clinical Pharmacology and Therapeutics|October 6, 2020
Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase I Clinical TrialPaul B Watkins, Rachel J Church, Jie Li, et al.
Frontiers in Genetics|April 9, 2025
Blood toxicogenomics reveals potential biomarkers for management of idiosyncratic drug-induced liver injuryRachel J Church, Benedict Anchang, Brian D Bennett, et al.
Plos One|October 9, 2020
Glutamate dehydrogenase as a biomarker for mitotoxicity; insights from furosemide hepatotoxicity in the mouseRachel J Church, Shelli J Schomaker, J Scott Eaddy, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 11, 2011
Allergic inflammation induces a persistent mechanistic switch in thromboxane-mediated airway constriction in the mouseJaime M Cyphert, Irving C Allen, Rachel J Church, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Experimental Biology and Medicine (Maywood, N.J.)|November 4, 2017
In silico modeling to optimize interpretation of liver safety biomarkers in clinical trialsRachel J Church, Paul B Watkins
Clinical and Translational Science|October 28, 2020
The Challenge of Interpreting Alanine Aminotransferase Elevations in Clinical Trials of New Drug CandidatesRachel J Church, Paul B Watkins
Hepatology (Baltimore, Md.)|March 6, 2018
ReplyRachel J Church, Paul B Watkins
Journal of Digestive Diseases|November 1, 2018
Serum biomarkers of drug-induced liver injury: Current status and future directionsRachel J Church, Paul B Watkins
Liver International : Official Journal of the International Association for the Study of the Liver|April 8, 2017
The transformation in biomarker detection and management of drug-induced liver injuryRachel J Church, Paul B Watkins
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 2012
Prostaglandin E(2) produced by the lung augments the effector phase of allergic inflammationRachel J Church, Leigh A Jania, Beverly H Koller
Clinical Pharmacology and Therapeutics|October 6, 2020
Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase I Clinical TrialPaul B Watkins, Rachel J Church, Jie Li, et al.
Frontiers in Genetics|April 9, 2025
Blood toxicogenomics reveals potential biomarkers for management of idiosyncratic drug-induced liver injuryRachel J Church, Benedict Anchang, Brian D Bennett, et al.
Plos One|October 9, 2020
Glutamate dehydrogenase as a biomarker for mitotoxicity; insights from furosemide hepatotoxicity in the mouseRachel J Church, Shelli J Schomaker, J Scott Eaddy, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 11, 2011
Allergic inflammation induces a persistent mechanistic switch in thromboxane-mediated airway constriction in the mouseJaime M Cyphert, Irving C Allen, Rachel J Church, et al.
Pageof 2